Authors: Damas, JK Gullestad, L Aass, H Simonsen, S Fjeld, JG Wikeby, L Ueland, T Eiken, HG Froland, SS Aukrust, P

Citation: Jk. Damas et al., Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure - Modulatory effect of intravenous immunoglobulin, J AM COL C, 38(1), 2001, pp. 187-193

Authors: Aukrust, P Berge, RK Ueland, T Aaser, E Damas, JK Wikeby, L Brunsvig, A Muller, F Forfang, K Froland, SS Gullestad, L

Citation: P. Aukrust et al., Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 485-491

Authors: Aukrust, P Gullestad, L Aass, H Fjeld, JG Wikeby, L Andreassen, AK Ihlen, H Simonsen, S Kjekshus, J Nitter-Hauge, S Ueland, T Froland, SS

Citation: P. Aukrust et al., Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response, CIRCULATION, 104(18), 2001, pp. E97-E98

Authors: Aukrust, P Gullestad, L Lappegard, KT Ueland, T Aass, H Wikeby, L Simonsen, S Froland, SS Mollnes, TE

Citation: P. Aukrust et al., Complement activation in patients with congestive heart failure - Effect of high-dose intravenous immunoglobulin treatment, CIRCULATION, 104(13), 2001, pp. 1494-1500

Authors: Gullestad, L Aass, H Fjeld, JG Wikeby, L Andreassen, AK Ihlen, H Simonsen, S Kjekshus, J Nitter-Hauge, S Ueland, T Lien, E Froland, SS Aukrust, P

Citation: L. Gullestad et al., Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure, CIRCULATION, 103(2), 2001, pp. 220-225